GSK stays a step ahead in RSV vaccine battle as Arexvy becomes available at US pharmacies
Fierce Pharma
AUGUST 17, 2023
As companies have flocked to compete in the new respiratory syncytial virus (RSV) vaccine market, GSK has had the best timing. | As companies have flocked to compete in the new respiratory syncytial virus (RSV) vaccine market, GSK has had the best timing. In May, the U.K. In May, the U.K.
223 
Let's personalize your content